Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.3 (
ATPase
)
65,361
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calponin, a protein isolated from smooth muscle and nonmuscle cells, has previously been shown to inhibit the actin-activated
ATPase
activity of myosin. Reports of the stoichiometry of binding range from 1
calponin
per actin to 1
calponin
per 3 actin monomers. We now report a detailed study of the binding of [14C]iodoacetamide-labeled
calponin
to actin. The labeling procedure did not significantly alter the binding constant of
calponin
to actin. The stoichiometry of binding was variable and dependent on ionic strength. Below 110 mM ionic strength, the stoichiometry of binding was 1:1. As the ionic strength was increased above 110 mM ionic strength, the stoichiometry shifted from 1:1 to 1
calponin
per 2 actin monomers. At physiological ionic strength, the binding exhibited a small degree of positive cooperativity and was adequately described by a single class of binding sites with an association constant of 6 x 10(6) M-1. The affinity decreased to 20% of this value in the presence of ATP. Irrespective of the ionic strength, actin formed bundles when saturation with
calponin
exceeded about 30%. Measurements of the rate of association were complicated by this bundling, but the upper limit for this reaction was placed at 10(6) M-1 s-1. The addition of
calponin
to actin-caldesmon complexes caused displacement of the caldesmon.
...
PMID:Characterization of calponin binding to actin. 754 21
Earlier, we proposed that the interaction of gizzard
calponin
with F-actin, promoting the inhibition of the actomyosin
ATPase
activity, involves the NH2-terminal portion of the
calponin
segment Ala145-Tyr182 (Mezgueldi, M., Fattoum, A., Derancourt, J., and Kassab, R. (1992) J. Biol. Chem. 267, 15943-15951). In this work, we have directly probed this region for actin binding sites using five peptide analogs covering different stretches of the sequence Thr133-Ile163. Co-sedimentation with F-actin, actomyosin
ATPase
measurements, and zero-length cross-linking reactions demonstrated that the 19-residue sequence Ala145-Ile163 is essential for actin interaction and
ATPase
inhibition. Furthermore, each peptide was tested for binding to the Ca(2+)-dependent proteins, caltropin and calmodulin, in both an actomyosin
ATPase
assay and an affinity chromatographic assay. The results revealed the 11-residue segment Gln153-Ile163, representing the COOH-terminal moiety of the F-actin binding sequence, as a crucial region for the high affinity binding of these regulatory proteins with concomitant removal of the
ATPase
inhibition. The 153-163 stretch contained also interactive sites for tropomyosin as assessed by affinity chromatography and spectrofluorometry. Collectively, the data support our initial results and highlight the ability of the multifunctional 145-163 region to serve as a potent regulatory domain of the smooth muscle
calponin
.
...
PMID:Characterization of the regulatory domain of gizzard calponin. Interactions of the 145-163 region with F-actin, calcium-binding proteins, and tropomyosin. 772 94
The controversial finding that the thick filaments of smooth muscle can be evanescent leads to the hypothesis that the large functional range of this muscle is accommodated by plastic rearrangements that place more thick filaments in series at longer lengths. Our preliminary finding that the shortening velocity and compliance of dog tracheal muscle were strongly dependent on adapted muscle length, while force was much less length dependent, supports this hypothesis (V.R. Pratusevich, C.Y. Seow, and L.E. Ford. Biophys. J. 66: A139, 1994). The hypothesis leads to two further corollaries. The first is that the lengthening of the thick filaments that must accompany their reformation will cause a series to parallel transition: fewer long filaments span the muscle length, but the longer filaments have more cross bridges acting in parallel. The second is that there is more than one activating mechanism in smooth muscle. It is known that myosin light chain phosphorylation activates the actomyosin
ATPase
, but this same phosphorylation also causes a structural change that facilitates filament formation. The consideration that the unaggregated, phosphorylated myosin must be prevented from competing with myosin in thick filaments and hydrolyzing ATP suggests that there must be a second mechanism that must allow the thin filaments to interact selectively with filamentous myosin. This need for a second activating mechanism may explain the presence of tropomyosin,
calponin
, and caldesmon on thin filaments. Although the two corollaries follow from the initial hypothesis, it should be emphasized that the three are not mutually dependent, and that the proof or disproof of any one of them would not prove or disprove the others.
...
PMID:Plasticity in smooth muscle, a hypothesis. 776 73
Recent studies of the smooth muscle contractile system indicate that Ca(2+)-dependent phosphorylation of the 20-kDa myosin light chains, modulation of phosphoprotein phosphatases, and phosphorylation of thin-filament proteins are all potential features of contractile system regulation. The thin-filament proteins caldesmon and
calponin
are known to inhibit actomyosin
ATPase
in vitro and actin sliding velocity in the in vitro motility assay. Inhibition of actomyosin
ATPase
is relieved by phosphorylation of caldesmon or
calponin
. The notion that caldesmon and
calponin
phosphorylation-dephosphorylation is important in the living smooth muscle cell was tested using canine tracheal smooth muscle strips labeled with 32P. We found that both caldesmon and
calponin
phosphorylation increased in response to stimulation with carbachol. Carbachol induced a biphasic increase in [Ca2+]i in canine tracheal smooth muscle, an early transient increase in myosin phosphorylation, which decayed to 0.4 mol Pi/mol light chain, and a rapid transient increase in tissue shortening velocity. Relative changes in caldesmon phosphorylation correlate best with force development and the [Ca2+]i transient, both of which follow a similar time course. Calponin phosphorylation appears to be a rapid transient event more similar to the transient increase in unloaded shortening velocity. Our results are consistent with a potential role for both caldesmon and
calponin
phosphorylation in regulating smooth muscle contraction.
...
PMID:Caldesmon and calponin phosphorylation in regulation of smooth muscle contraction. 776 86
Calponin has been implicated in the regulation of smooth muscle contraction as a result of its ability to inhibit the actin-activated Mg
ATPase
of smooth muscle myosin. This inhibitory effect is abolished by phosphorylation of
calponin
by Ca2+/calmodulin-dependent protein kinase II or protein kinase C, and restored following dephosphorylation by a type 2A protein phosphatase. Confocal immunofluorescent images of isolated smooth muscle cells colabeled with antibodies to
calponin
and actin or to
calponin
and tropomyosin indicate that
calponin
is present on thin filaments throughout the cell cytoplasm. Both
calponin
phosphorylation and myosin light chain phosphorylation increased in intact smooth muscle tissue strips when they contracted in response to carbachol or the phosphatase inhibitor okadaic acid. These results support the hypothesis that
calponin
phosphorylation-dephosphorylation plays a role in regulating smooth muscle contraction.
...
PMID:Calponin and smooth muscle regulation. 776 87
Calponin, a major calmodulin-, actin-, and tropomyosin-binding protein in smooth muscle, interacted with brain S100 and the properties of the interaction were investigated in detail. From fluorescence labeling and chemical cross-linking experiments, the apparent Kd value was calculated to be 7 x 10(7) M-1 in the presence of Ca2+ with 1 mol of S100 bound per mol of
calponin
. The addition of S100 to the mixture of
calponin
and F-actin caused the removal of
calponin
from actin filaments in the presence of Ca2+ but not in the presence of EGTA or Zn2+. Ca2+ and S100 could relieve
calponin
-induced actomyosin Mg(2+)-ATPase inhibition. Both the removal of
calponin
from F-actin and the restoration of
ATPase
inhibition by S100 were more effective than those by calmodulin. At low ionic strength, the binding was observed irrespective of Ca2+ concentration and it was greatly weakened with increasing salt concentration. The formation of the complex in the presence of Ca2+ was less sensitive, with only 45% inhibition at 100 mM NaCl, where the complex in the absence of Ca2+ had almost disappeared. This was confirmed by S-100 Sepharose 4B chromatography. Addition of Ca2+ and S100 also led to a decrease in the affinity of
calponin
for tropomyosin. Domain mapping with chymotryptic digestion revealed that the S100 binding site resided within the N-terminal 22 kDa fragment of
calponin
, where the bindings of calmodulin and actin also occur.
...
PMID:Calcium-dependent regulation of smooth muscle calponin by S100. 779 69
Calponin inhibits actomyosin Mg2+
ATPase
and is proposed to regulate smooth muscle contraction; however, the mechanism by which it exerts its effect and the regulation of its behavior is still under investigation. The proposed methods by which
calponin
regulation is effected include reversible phosphorylation of
calponin
which would allow contraction to occur and regulation by interaction with calcium-calmodulin. However, several investigators have been unable to find evidence of in vivo phosphorylation of
calponin
, and the affinity between
calponin
and calmodulin is not high enough to suggest that this interaction is biologically significant. In this paper, we present an alternative method of
calponin
regulation via calcium-caltropin and describe the
calponin
-caltropin complex for the first time. Caltropin, a calcium-binding protein isolated from smooth muscle, is a dimer under native conditions and interacts with
calponin
in a calcium-dependent fashion in the ratio of 2 mol of dimer: 1 mol of
calponin
. The formation of this complex can be monitored by following the fluorescence of an acrylodan label on cysteine 273 of
calponin
, which undergoes a 35-nm blue shift in wavelength peak from 505 to 470 nm when
calponin
becomes complexed with caltropin. This fluorescence change when titrated with calcium indicates that the concentration of calcium required for complex formation is approximately 10(-5) M, corresponding to the low-affinity calcium-binding sites of caltropin. This complex was further characterized by circular dichroism (CD).(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Smooth muscle calponin-caltropin interaction: effect on biological activity and stability of calponin. 818 Jan 79
Calponin isolated from chicken gizzard smooth muscle binds in vitro to actin in a Ca(2+)-independent manner and thereby inhibits the actin-activated Mg(2+)-
adenosinetriphosphatase
of smooth muscle myosin. This inhibition is relieved when
calponin
is phosphorylated by protein kinase C or Ca2+/calmodulin-dependent protein kinase II, suggesting that
calponin
is involved in thin filament-associated regulation of smooth muscle contraction. To further examine this possibility,
calponin
was isolated from toad stomach smooth muscle, characterized biochemically, and localized in intact isolated cells. Toad stomach
calponin
had the same basic biochemical properties as
calponin
from other sources. Confocal immunofluorescence microscopy revealed that
calponin
in intact smooth muscle cells was localized to long filamentous structures that were colabeled by antibodies to actin or tropomyosin. Preservation of the basic biochemical properties of
calponin
from species to species suggests that these properties are relevant for its in vivo function. Its colocalization with actin and tropomyosin indicates that
calponin
is associated with the thin filament in intact smooth muscle cells.
...
PMID:Characterization and confocal imaging of calponin in gastrointestinal smooth muscle. 823 86
Calponin is a thin filament-associated protein that is implicated in the regulation and maintenance of smooth muscle contraction. Molecular cloning of chicken gizzard
calponin
indicated the presence of two isoforms, alpha and beta, the expression of the alpha-isoform being uniformly more abundant in various smooth muscle tissues [Takahashi, K. & Nadal-Ginard, B. (1991) J. Biol. Chem. 266, 13284-13288]. For the long-range goal of understanding of the structure and function of
calponin
, we have started bacterial expression and site-directed mutagenesis of alpha
calponin
. The amino acid composition and N-terminal sequence of the recombinant alpha
calponin
were found to be identical to those deduced from its nucleotide sequence. Recombinant alpha
calponin
is capable of binding to calmodulin, troponin C, tropomyosin, and actin, and of inhibiting skeletal muscle acto-subfragment-1
ATPase
activity. A mutant alpha
calponin
with a replacement in the putative inhibitory region (residues 146-171) has impaired ability to inhibit the acto-subfragment-1
ATPase
activity, suggesting that this region of
calponin
may be involved in the modulation of the actin-myosin interactions.
...
PMID:Characterization of wild type and mutant chicken gizzard alpha calponin expressed in E. coli. 827 52
Calponin, a calmodulin-binding protein of smooth muscle that inhibits the actin-myosin interaction by binding to actin, was shown to bind to myosin and to stimulate the
ATPase
activity of myosin to some extent. Actin abolished this myosin-linked, stimulatory effect of
calponin
. Ca(2+)-calmodulin affected neither the myosin-binding activity nor the stimulatory effect of
calponin
. We further presented a few data which suggest that
calponin
may exert regulatory activity toward myosin in quite a different way from caldesmon, another smooth muscle protein that binds to myosin, actin, and calmodulin.
...
PMID:Stimulatory effect of calponin on myosin ATPase activity. 837 Jun 58
<< Previous
1
2
3
4
5
6
Next >>